Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Related Articles by Review for PubMed (Select 18073583)

1.
2.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
4.

Genetics of aminoglycoside-induced and prelingual non-syndromic mitochondrial hearing impairment: a review.

Bindu LH, Reddy PP.

Int J Audiol. 2008 Nov;47(11):702-7. doi: 10.1080/14992020802215862. Review.

PMID:
19031229
5.

The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.

Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K.

Health Technol Assess. 2007 Nov;11(45):iii-iv, ix-221. Review.

6.

Cystic fibrosis: cost of illness and considerations for the economic evaluation of potential therapies.

Krauth C, Jalilvand N, Welte T, Busse R.

Pharmacoeconomics. 2003;21(14):1001-24. Review.

PMID:
13129414
7.

Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.

Robinson M, Palmer S, Sculpher M, Philips Z, Ginnelly L, Bowens A, Golder S, Alfakih K, Bakhai A, Packham C, Cooper N, Abrams K, Eastwood A, Pearman A, Flather M, Gray D, Hall A.

Health Technol Assess. 2005 Jul;9(27):iii-iv, ix-xi, 1-158. Review.

8.

Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.

Wilby J, Kainth A, Hawkins N, Epstein D, McIntosh H, McDaid C, Mason A, Golder S, O'Meara S, Sculpher M, Drummond M, Forbes C.

Health Technol Assess. 2005 Apr;9(15):1-157, iii-iv. Review.

9.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
10.

The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.

Fox M, Mealing S, Anderson R, Dean J, Stein K, Price A, Taylor RS.

Health Technol Assess. 2007 Nov;11(47):iii-iv, ix-248. Review.

11.

Costs, quality of life and treatment compliance associated with antibiotic therapies in patients with cystic fibrosis: a review of the literature.

Weiner JR, Toy EL, Sacco P, Duh MS.

Expert Opin Pharmacother. 2008 Apr;9(5):751-66. doi: 10.1517/14656566.9.5.751. Review.

PMID:
18345953
12.

Extended-interval once-daily dosing of aminoglycosides in adult and pediatric patients with cystic fibrosis.

Prescott WA Jr, Nagel JL.

Pharmacotherapy. 2010 Jan;30(1):95-108. doi: 10.1592/phco.30.1.95. Review.

PMID:
20030477
13.

Mitochondrial 12S rRNA mutations associated with aminoglycoside ototoxicity.

Guan MX.

Mitochondrion. 2011 Mar;11(2):237-45. doi: 10.1016/j.mito.2010.10.006. Epub 2010 Nov 1. Review.

PMID:
21047563
14.

New developments in aminoglycoside therapy and ototoxicity.

Xie J, Talaska AE, Schacht J.

Hear Res. 2011 Nov;281(1-2):28-37. doi: 10.1016/j.heares.2011.05.008. Epub 2011 May 27. Review.

15.

Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis.

Prayle A, Watson A, Fortnum H, Smyth A.

Thorax. 2010 Jul;65(7):654-8. doi: 10.1136/thx.2009.131532. Review.

16.

Cisplatin and aminoglycoside antibiotics: hearing loss and its prevention.

Schacht J, Talaska AE, Rybak LP.

Anat Rec (Hoboken). 2012 Nov;295(11):1837-50. doi: 10.1002/ar.22578. Epub 2012 Oct 8. Review.

17.

Ototoxicity in preterm infants: effects of genetics, aminoglycosides, and loud environmental noise.

Zimmerman E, Lahav A.

J Perinatol. 2013 Jan;33(1):3-8. doi: 10.1038/jp.2012.105. Epub 2012 Aug 9. Review.

PMID:
22878560
18.

Genetic factors in aminoglycoside toxicity.

Fischel-Ghodsian N.

Pharmacogenomics. 2005 Jan;6(1):27-36. Review.

PMID:
15723603
19.

Antioxidant therapy attenuates aminoglycoside-induced hearing loss.

Schacht J.

Ann N Y Acad Sci. 1999 Nov 28;884:125-30. Review.

PMID:
10842589
20.

The potential utility of pharmacogenetic testing in psychiatry.

Gardner KR, Brennan FX, Scott R, Lombard J.

Psychiatry J. 2014;2014:730956. doi: 10.1155/2014/730956. Epub 2014 Dec 17. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk